Filing Flows

Filing Flows › Comparisons › SPRY vs LFVN

ARS Pharmaceuticals vs Lifevantage: SPRY and LFVN compared

ARS Pharmaceuticals is the larger company: $37.7M of revenue in its latest quarter (Q3 2026) against $37.1M for Lifevantage (Q3 2026). ARS Pharmaceuticals is growing faster (+16% against -22% a year earlier). Lifevantage is more profitable, with an operating margin of -0.4% against -90.6%.

ARS Pharmaceuticals vs Lifevantage, latest quarterARS Pharmaceuticals vs Lifevantage, latest quarterARS Pharmaceuticals (SPRY)Lifevantage (LFVN)Revenue$37.7M$37.1MRevenue growth, Y/Y+16%-22%Operating margin-90.6%-0.4%Net margin-94.4%-0.5%

Where the money goes: SPRY and LFVN

ARS Pharmaceuticals (SPRY) · Q3 2026

ARS Pharmaceuticals, Q3 2026: revenue $37.7M (+16% year over year), operating margin -90.6%, net loss $35.6M, operating cash flow −$33.7M. The chart follows the revenue to costs, profit and cash.

Lifevantage (LFVN) · Q3 2026

Lifevantage, Q3 2026: revenue $37.1M (-22% year over year), operating margin -0.4%, net loss $196K, operating cash flow $533K. The chart follows the revenue to costs, profit and cash.

ARS Pharmaceuticals revenue by segment, Q3 2026ARS Pharmaceuticals revenue by segment, Q3 2026Product$33.4MRevenue Under Supply Agreements$2.6MRevenue Under Collaboration Agree…$1.7M
Lifevantage revenue by segment, Q3 2026Lifevantage revenue by segment, Q3 2026Protandim$18.0MTrue Science Product Line$7.6MLife Vantage Product Line$4.8MAXIO Product Line$2.9M
ARS Pharmaceuticals (SPRY)Lifevantage (LFVN)
Latest quarterQ3 2026Q3 2026
Revenue$37.7M$37.1M
Revenue growth, Y/Y+16%-22%
Operating margin-90.6%-0.4%
Net earnings−$35.6M−$196K
Net margin-94.4%-0.5%
Operating cash flow−$33.7M$533K

Where the revenue comes from

ARS Pharmaceuticals

Lifevantage

Questions

Which is bigger, ARS Pharmaceuticals or Lifevantage?

ARS Pharmaceuticals is the larger company: $37.7M of revenue in its latest quarter (Q3 2026) against $37.1M for Lifevantage (Q3 2026).

Is ARS Pharmaceuticals or Lifevantage growing faster?

ARS Pharmaceuticals is growing faster (+16% against -22% a year earlier).

Which is more profitable, ARS Pharmaceuticals or Lifevantage?

Lifevantage is more profitable, with an operating margin of -0.4% against -90.6%.

More: ARS Pharmaceuticals earnings · how ARS Pharmaceuticals makes money · Lifevantage earnings · how Lifevantage makes money

From the companies' latest 10-Q, 10-K or earnings release (10-Q filed Nov 5, 2026; 10-Q filed Nov 9, 2026). Fiscal quarters can end on different dates. Not investment advice.